My Account Log in

7 options

Of medicines and markets : intellectual property and human rights in the free trade era / Angelina Snodgrass Godoy.

De Gruyter Stanford University Press Backlist eBook-Package 2000-2013 Available online

View online

EBSCOhost Academic eBook Collection (North America) Available online

View online

EBSCOhost Ebook Business Collection Available online

View online

EBSCOhost eBook Community College Collection Available online

View online

Ebook Central Academic Complete Available online

View online

Ebook Central University Press Available online

View online

Ebscohost Ebooks University Press Collection (North America) Available online

View online
Format:
Book
Author/Creator:
Godoy, Angelina Snodgrass.
Series:
Stanford studies in human rights.
Stanford studies in human rights
Language:
English
Subjects (All):
Drug accessibility--Central America.
Drug accessibility.
Drugs--Patents.
Drugs.
Free trade--Central America.
Free trade.
Human rights--Central America.
Human rights.
Intellectual property--Central America.
Intellectual property.
Pharmaceutical policy--Central America.
Pharmaceutical policy.
Right to health--Central America.
Right to health.
Physical Description:
xiv, 183 p. : ill.
Edition:
1st ed.
Place of Publication:
Stanford, California : Stanford University Press, c2013.
Language Note:
English
Summary:
Central American countries have long defined health as a human right. But in recent years regional trade agreements have ushered in aggressive intellectual property reforms, undermining this conception. Questions of IP and health provisions are pivotal to both human rights advocacy and "free" trade policy, and as this book chronicles, complex political battles have developed across the region. Looking at events in Costa Rica, El Salvador, and Guatemala, Angelina Godoy argues that human rights advocates need to approach intellectual property law as more than simply a roster of regulations. IP represents the cutting edge of a global tendency to value all things in market terms: Life forms—from plants to human genetic sequences—are rendered commodities, and substances necessary to sustain life—medicines—are restricted to insure corporate profits. If we argue only over the terms of IP protection without confronting the underlying logic governing our trade agreements, then human rights advocates will lose even when they win.
Contents:
Frontmatter
Contents
Foreword
Acronyms and Abbreviations
Acknowledgments
1. Trading Health for Wealth
2. A Primer on Pharmaceutical Intellectual Property
3. Market Failures and Fallacies
4. Local Politics, Strange Bedfellows, and the Challenges of Human Rights Mobilization
5. Patient Advocacy and Access to Medicines Litigation
6. Writing Globalization’s Rule Book
Notes
References
Index
Notes:
Bibliographic Level Mode of Issuance: Monograph
Includes bibliographical references and index.
ISBN:
9780804786577
0804786577
OCLC:
846551598

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account